Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2003-03-07
2009-08-18
Hui, San-ming (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
active
07576133
ABSTRACT:
Systemic delivery of Modafinil to the nasal mucous membrane elicits rapid systemic therapeutic response with reduced side effects compared to current methods of administration.
REFERENCES:
patent: 5618845 (1997-04-01), Grebow et al.
patent: 2293103 (1996-03-01), None
Remington's Pharmaceutical Sciences, 18th ed., 1990, pp. 1132-1134, 1613, 1629-1632, and 1694-1712.
Remington's Pharmaceutical Sciences, 18th ed., 1990, pp. 1316-1317.
Abstract of Jasinski et al., Clinical Neuropharmacology, 2000;23(3):149-156.
Hou et al., Zhongguo Yao Li Xue Bao. Sep. 1999;20(9):813-8.
Section on PROVIGIL,Physician's Desk Reference, 2001, p. 1093.
Lawyer Carl Henry
Lawyer Edward Zadok
Lawyer Matthew Carl
Hui San-ming
McDonnell Boehnen & Hulbert & Berghoff LLP
LandOfFree
Methods and compositions for nasal administration of modafinil does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for nasal administration of modafinil, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for nasal administration of modafinil will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4100305